PD-L1 expressing circulating tumour cells in head and neck cancers

PD-L1 expressing circulating tumour cells in head and neck cancers

Abstract Background Blockade of the PD-1/PD-L1 immune checkpoint pathway is emerging as a promising immunotherapeutic approach for the management and treatment of head and neck cancer patients who do not respond to 1st/2nd line therapy. However, as checkpoint inhibitors are cost intensive, identifyi...

Full description

Bibliographic Details
Main Authors: Arutha Kulasinghe, Chris Perry, Liz Kenny, Majid E. Warkiani, Colleen Nelson, Chamindie Punyadeera
Format: Article
Language:English
Published: BMC 2017-05-01
Series:BMC Cancer
Subjects:
PD-L1
Head and neck cancers
Circulating tumour cells
Non-invasive tools
Liquid biopsy
Online Access:http://link.springer.com/article/10.1186/s12885-017-3316-3

Similar Items

Similar Items